CIK 0000721371
- Large accelerated filer
CARDINAL HEALTH INC
Sign in to watch- Ticker
- CAH
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Jun 30
- Incorporated
- OH
- Entity type
- Operating
- EIN
- 310958666
- Phone
- +1 614-757-3033
- Business address
- 7000 CARDINAL PLACE, DUBLIN, OH, 43017
- Former names
- CARDINAL HEALTH INC, CARDINAL DISTRIBUTION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-07-24 | Blake Mark R EVP - Strategy & Corp. Dev. | Sale | −23,114 | $73.41 | $1.7M | 24,416 |
| 2014-07-24 | Blake Mark R EVP - Strategy & Corp. Dev. | Exercise or conversion · Employee Stock Option (right to buy) | −14,808 | 7,404 | ||
| 2014-07-24 | Blake Mark R EVP - Strategy & Corp. Dev. | Exercise or conversion · Employee Stock Option (right to buy) | −8,306 | 16,614 | ||
| 2014-07-23 | FINN JOHN F Director | Gift | −49 | 22,908 | ||
| 2014-07-23 | FINN JOHN F Director | Gift | +49 | 21,074 | ||
| 2014-07-14 | Henderson Jeffrey William Chief Financial Officer | Sale | −23,632 | $70.65 | $1.7M | 83,464 |
| 2014-05-19 | Blake Mark R EVP - Strategy & Corp. Dev. | Sale | −4,703 | $66.50 | $313K | 24,416 |
| 2014-05-13 | Blake Mark R EVP - Strategy & Corp. Dev. | Sale | −2,822 | $66.50 | $188K | 29,119 |
| 2014-05-12 | Barrett George S Chairman and CEO | Exercise or conversion | +8,416 | $44.16 | $372K | 342,518 |
| 2014-05-12 | Barrett George S Chairman and CEO | Sale | −8,416 | $65.04 | $547K | 334,102 |
| 2014-05-12 | Barrett George S Chairman and CEO | Exercise or conversion · Employee Stock Option (right to buy) | −8,416 | 0 | ||
| 2014-05-07 | FINN JOHN F Director | Grant or award · Phantom Stock | +233 | $64.22 | $15K | 15,556 |
| 2014-05-07 | DARDEN CALVIN Director | Grant or award · Phantom Stock | +70 | $64.22 | $4K | 4,835 |
| 2014-05-07 | BRITT GLENN Director | Grant or award · Phantom Stock | +428 | $64.22 | $27K | 10,266 |
| 2014-05-07 | Henderson Jeffrey William Chief Financial Officer | Sale | −27,031 | $63.83 | $1.7M | 107,096 |
| 2014-04-16 | Casey Donald M Jr. CEO, Medical Segment | Shares withheld for taxes | −251 | $67.21 | $17K | 44,002 |
| 2014-03-07 | Stephen Falk T EVP, Gen. Counsel & Corp. Sec. | Gift | −200 | 24,039 | ||
| 2014-02-11 | Kaufmann Michael C CEO, Pharmaceutical Segment | Exercise or conversion | +133,136 | $27.29 | $3.6M | 249,105 |
| 2014-02-11 | Kaufmann Michael C CEO, Pharmaceutical Segment | Exercise or conversion | +182,359 | $30.94 | $5.6M | 431,464 |
| 2014-02-11 | Kaufmann Michael C CEO, Pharmaceutical Segment | Sale | −315,495 | $67.57 | $21.3M | 115,969 |
Page 48 of 55 · 1,092 trades